The most obvious and simple solution for smokers to protect their health is to quit smoking immediately. However, as we have seen, many smokers struggle with their habit and end up continuing to smoke. In this case, the realistic approach should be to determine how to reduce their health risks rather than simply abandoning these smokers who would otherwise continue smoking. The answer lies in scientifically proven smokeless technologies, which have proven to be effective tools for reducing the harmful effects of cigarette smoking, although they work slowly.
Smokeless products work by eliminating combustion. When cigarettes are lit, tobacco is burned, producing toxic smoke. On the other hand, smokeless alternatives prevent the burning of tobacco, thereby eliminating the release of smoke and accompanying toxic chemicals. The category of smokeless products is diverse and is constantly producing more innovative technologies to assist smokers. Some products in this category include electronic cigarettes, which do not contain tobacco but have flavored e-liquids that are heated, and heated tobacco products (HTPs), which are another excellent technology based on the principle of heating without combustion. These products heat tobacco rather than burn it, providing smokers with a similar experience but with much lower risk. Other products like snuff or nicotine pouches for oral use also prevent smokers from inhaling toxic cigarette smoke. While these products may not be risk-free, scientific evidence has shown that they can minimize the harm caused by tobacco use and reduce the risk of tobacco-related illnesses caused by smoking.
As more and more innovative products are being utilized to reduce the harm caused by tobacco use, an increasing number of scientists, public health experts, and governments are recognizing the role that smoke-free alternatives can play in addressing the global public health issue of smoking. The effectiveness of these products can be seen in Japan, where cigarette sales have dropped fivefold following the introduction of heated tobacco products. The UK, New Zealand, and a few other countries have also incorporated smoke-free products as part of their public health strategies to mitigate the harm caused by tobacco and to regulate them accordingly.
These countries understand the relative health benefits of smokeless alternatives, respect smokers' preferences, and prioritize better public health outcomes. They are benefiting from the flexibility and openness demonstrated by innovative solutions supported by science, which are designed to reduce harm to smokers. If more countries were to adopt such policies, it could significantly reduce the harm caused by smoking to smokers worldwide.
Statement:
This article is compiled from information provided by a third party and is intended for industry-related communication and learning purposes only.
This article does not reflect the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the content. The compilation of this article is for industry communication and research purposes only.
Due to limitations in translation ability, the translated article may not accurately convey the original meaning. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government in regards to any domestic, Hong Kong, Macau, Taiwan, or foreign-related assertions and positions.
The copyright of compiled information belongs to the original media and author, and if there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
